INNATE PHARMA PROVIDES UPDATE FROM REGULATORY AGENCIES ON LACUTAMAB TELLOMAK TRIALGlobeNewsWire • 01/09/20
Innate Pharma Rallies On Acceptance Of European Regulatory Application For Leukemia DrugBenzinga • 01/02/20
The European Medicines Agency accepts the regulatory submission for Lumoxiti in relapsed or refractory hairy cell leukemiaGlobeNewsWire • 01/02/20